A study to assess the etiology, risk factors, distribution, characteristics and outcome of multisystem inflammatory syndrome in children in Hadoti region of Rajasthan
DOI:
https://doi.org/10.18203/2349-3291.ijcp20223417Keywords:
MIS-C, SARS-CoV-2, Real time–reverse transcription-polymerase chain reaction, LDH, DAMAAbstract
Background: Aim and objectives of the study was to assess the etiology, risk factors, distribution, characteristics and outcome of multisystem inflammatory syndrome in children (MIS-C) in Hadoti region of Rajasthan.
Methods: A cross-sectional study was conducted, based on notified suspected cases of MIS-C with COVID-19. The records were then classified according to the definition of a ‘confirmed case. Treatment was also recorded immunoglobulin, antibiotics, corticoid, anticoagulant and oxygen supplementation. The outcome of the subjects was also recorded.
Results: Majority of the subjects belonged to 1-6 years (56.6%) with 62.3% males and 37.7% females. Fever, rashes, cough, vomiting, abdominal pain, throat pain, hematuria and decreased appetite was present among 100.0%, 47.2%, 37.7%, 39.6%, 22.6%, 15.1%, 13.2% and 3.8% respectively. C-reactive protein, D-dimer, erythrocyte sedimentation rate (ESR), ferritin and lactate dehydrogenase (LDH) were present among 94.3%, 92.5%, 88.7%, 75.5% and 60.4% respectively. Discharge against medical advice (DAMA) was done for 5.7%, death among 7.5%, discharge among 84.9% and 1.9% were referred to higher centre.
Conclusions: The risk of mortality was greater in MIS-C patients in LMICs despite reduced rates of ICU hospitalisation and use of mechanical ventilation. For the causation, ideal preventative and treatment strategies, and long-term results of the MIS-C patients, further proof is required.
References
Smith C, Odd D, Harwood R, Ward J, Linney M, Clark M, et al. Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat Med. 2022;28(1):185-92.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259-69.
Kahn R, Berg S, Berntson L, Berthold E, Brodin P, Bäckström F, et al. Population-based study of multisystem inflammatory syndrome associated with COVID-19 found that 36% of children had persistent symptoms. Acta Paediatr. 2021;111(2):354-62.
Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med. 2020;383(4):334-46.
World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. Scientific Brief. 2020. Available at: https://www.who.int/news-room/commentaries/ detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed on 12 October 2022.
Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP, et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolescent Health. 2021;5(5):323-31.
Payne AB, Gilani Z, Godfred-Cato S, Belay ED, Feldstein LR, Patel MM, et al. Incidence of multisystem inflammatory syndrome in children among us persons infected with SARS-CoV-2. JAMA Network Open. 2021;4(6):e2116420.
Martin B, DeWitt PE, Russell S, Anand A, Bradwell KR, Bremer C, et al. Characteristics, outcomes, and severity risk factors associated with SARS-CoV-2 infection among children in the US national COVID cohort collaborative. JAMA Network Open. 2022;5(2):e2143151.
Ludwikowska KM, Okarska-Napiera»a M, Dudek N. MOIS CoR Study Group. Sci Rep. 2021;11(1):23562.
Bergman J, Ballin M, Nordstr€om A, Nordstr€om P. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. Eur J Epidemiol. 2021;36(3):287-98.
Curtis JR, Zhou X, Rubin DT, Reinisch W, Yazdany J, Robinson PC, et al. Characteristics, comorbidities, and outcomes of SARS-CoV-2 infection in patients with autoimmune conditions treated with systemic therapies: a population based study. J Rheumatol. 2021;49(3):320-9.
Levy M, Recher M, Hubert H, Javouhey E, Fléchelles O, Leteurtre S, et al. Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France. JAMA. 2022;327(3):281-3.
The Swedish Paediatric Society. Recommendation for Vaccination Mot Covid-19 for Sarskilda Grupper av barn fran 5 ars alder [Swedish]. 2021.
Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, Klein JD, Bhutta ZA. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20(11):e276-88.
Jiang L, Tang K, Irfan O, Li X, Zhang E, Bhutta Z. Epidemiology, Clinical Features, and Outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C) and Adolescents-a Live Systematic Review and Meta-analysis. Curr Pediatr Rep. 2022;10(2):19-30.
DeBiasi RL, Harahsheh AS, Srinivasalu H, Krishnan A, Sharron MP, Parikh K, et al. Multisystem inflammatory syndrome of children: subphenotypes, risk factors, biomarkers, cytokine profiles, and viral sequencing. J Pediatrics. 2021;237:125-35.
Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr Respir Rev. 2021;38:51-7.
Kim L, Whitaker M, O’Halloran A, Kambhampati A, Chai SJ, Reingold A, et al. Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 states, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1081-8.
Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection. Circulation. 2020;142(1):4-6.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-25.
Bolia R, Dhanesh Goel A, Badkur M, Jain V. Gastrointestinal manifestations of pediatric coronavirus disease and their relationship with a severe clinical course: a systematic review and meta-analysis. J Trop Pediatr. 2021;67(2).
Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP, et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health. 2021;5(5):323-31.
Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021;180(7):2019-34.
Zhao Y, Yin L, Patel J, Tang L, Huang Y. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: a metaanalysis. J Med Virol. 2021;93(7):4358-69.
Haghighi Aski B, Manafi Anari A, AbolhasanChoobdar F, Zareh Mahmoudabadi R, Sakhaei M. Cardiac abnormalities due to multisystem inflammatory syndrome temporally associated with Covid-19 among children: a systematic review and meta-analysis. IJC Heart & Vasculature. 2021;33:100764.
Harwood R, Allin B, Jones CE, Whittaker E. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. Lancet Child Adolesc Health. 2021;5(2):133-41.
Dhar D, Dey T, Samim MM, Padmanabha H, Chatterjee A, Naznin P. Systemic inflammatory syndrome in COVID-19–SISCoV study: systematic review and meta-analysis. Pediatric Res. 2022;91(6):1334-49.
